Key Segmentation
By Component
- Software
- Services
By Delivery Mode
- Cloud-Based
- On-Premise
- Mobile-Based
By Prescription Type
- Controlled Substances
- Non-Controlled Substances
By End-User
- Hospitals
- Physician Offices
- Pharmacies
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include Surescripts, Veradigm, Epic Systems, Oracle Health, DrFirst, RxNT, athenahealth, NewCrop, eClinicalWorks, and Change Healthcare, among others.
Continued expansion of mobile-first prescribing applications and the continued integration of artificial intelligence-enabled clinical decision support represent the two most significant opportunities shaping the market's next phase of growth.
Growth is primarily driven by growing emphasis on medication error reduction, combined with expanding government mandates requiring electronic transmission of controlled-substance prescriptions.
By Component, Software dominated the market with a 65.45% share in 2025, reflecting core licensing demand across hospitals and physician practices.
North America commanded the largest share at 45.34% in 2025, underpinned by comprehensive federal and state electronic prescribing mandates.
